Annual CFI
-$192.47 M
-$192.47 M-100.00%
December 31, 2024
Summary
- As of March 15, 2025, AVBP annual cash flow from investing activities is -$192.47 million, with the most recent change of -$192.47 million (-100.00%) on December 31, 2024.
Performance
AVBP Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFI
-$192.47 M
-$192.47 M-100.00%
December 31, 2024
Summary
- As of March 15, 2025, AVBP quarterly cash flow from investing activities is -$192.47 million, with the most recent change of -$192.47 million (-100.00%) on December 31, 2024.
- Over the past year, AVBP quarterly CFI has dropped by -$192.47 million (-100.00%).
- AVBP quarterly CFI is now -869.86% below its all-time high of $25.00 million, reached on December 31, 2023.
Performance
AVBP Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFI
-$192.47 M
-$217.47 M-869.86%
December 31, 2024
Summary
- As of March 15, 2025, AVBP TTM cash flow from investing activities is -$192.47 million, with the most recent change of -$217.47 million (-869.86%) on December 31, 2024.
- Over the past year, AVBP TTM CFI has dropped by -$217.47 million (-869.86%).
- AVBP TTM CFI is now -869.86% below its all-time high of $25.00 million, reached on June 30, 2024.
Performance
AVBP TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
AVBP Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -100.0% | -100.0% | -869.9% |
| 3 y3 years | - | -100.0% | -869.9% |
| 5 y5 years | - | -100.0% | -869.9% |
AVBP Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | <-9999.0% | at low | -869.9% | at low | -869.9% | at low |
| 5 y | 5-year | <-9999.0% | at low | -869.9% | at low | -869.9% | at low |
| alltime | all time | <-9999.0% | at low | -869.9% | at low | -869.9% | at low |
ArriVent BioPharma Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | -$192.47 M(<-9900.0%) | -$192.47 M(<-9900.0%) | -$192.47 M(-869.9%) |
| Sep 2024 | - | $0.00(0.0%) | $25.00 M(0.0%) |
| Jun 2024 | - | $0.00(-100.0%) | $25.00 M(>+9900.0%) |
| Dec 2023 | $0.00 | $25.00 M(>+9900.0%) | $0.00(-100.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2023 | - | $0.00(-100.0%) | -$25.00 M(0.0%) |
| Jun 2023 | - | -$25.00 M(<-9900.0%) | -$25.00 M(<-9900.0%) |
| Dec 2022 | $0.00 | - | - |
| Sep 2022 | - | $0.00 | $0.00 |
FAQ
- What is ArriVent BioPharma annual cash flow from investing activities?
- What is the all time high annual CFI for ArriVent BioPharma?
- What is ArriVent BioPharma annual CFI year-on-year change?
- What is ArriVent BioPharma quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for ArriVent BioPharma?
- What is ArriVent BioPharma quarterly CFI year-on-year change?
- What is ArriVent BioPharma TTM cash flow from investing activities?
- What is the all time high TTM CFI for ArriVent BioPharma?
- What is ArriVent BioPharma TTM CFI year-on-year change?
What is ArriVent BioPharma annual cash flow from investing activities?
The current annual CFI of AVBP is -$192.47 M
What is the all time high annual CFI for ArriVent BioPharma?
ArriVent BioPharma all-time high annual cash flow from investing activities is $0.00
What is ArriVent BioPharma annual CFI year-on-year change?
Over the past year, AVBP annual cash flow from investing activities has changed by -$192.47 M (-100.00%)
What is ArriVent BioPharma quarterly cash flow from investing activities?
The current quarterly CFI of AVBP is -$192.47 M
What is the all time high quarterly CFI for ArriVent BioPharma?
ArriVent BioPharma all-time high quarterly cash flow from investing activities is $25.00 M
What is ArriVent BioPharma quarterly CFI year-on-year change?
Over the past year, AVBP quarterly cash flow from investing activities has changed by -$192.47 M (-100.00%)
What is ArriVent BioPharma TTM cash flow from investing activities?
The current TTM CFI of AVBP is -$192.47 M
What is the all time high TTM CFI for ArriVent BioPharma?
ArriVent BioPharma all-time high TTM cash flow from investing activities is $25.00 M
What is ArriVent BioPharma TTM CFI year-on-year change?
Over the past year, AVBP TTM cash flow from investing activities has changed by -$217.47 M (-869.86%)